Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia (CML)

Explore clinical trials studying Chronic Myelogenous Leukemia (CML). Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia (CML) trial results

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT01351545

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
View all 142 locations
View Trial Details
Completed

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

NCT02730299

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +27 more
Locations
  • UCLA Los Angeles, California, United States
  • City of Hope Los Angeles, California, United States
  • Stanford University Cancer Institute Palo Alto, California, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
View all 52 locations
View Trial Details
Completed

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

NCT03959241

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 39 locations
View Trial Details
Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

NCT01243489

Conditions
Behavior, Bone Marrow Diseases, Chromosome Aberrations, +19 more
Locations
  • Onkologische Schwerpunktpraxis Celle Celle, Germany
  • Onkozentrum Dresden, Gemeinschaftspraxis Dres. Göhler & Dörfel Dresden, Germany
  • Gemeinschaftspraxis Hämatologie - Onkologie, BAG Freiberg-Richter / Jacobasch / Illmer / Wolf Dresden, Germany
  • Gemeinschaftspraxis für Hämatologie und Onkologie Erfurt, Germany
View all 23 locations
View Trial Details

Related conditions